| Literature DB >> 32624004 |
Martin Kaj Fridh Nielsen1,2, Jesper Frank Christensen3, Thomas Leth Frandsen1, Troels Thorsteinsson1, Lars Bo Andersen4,5, Karl Bang Christensen6, Peder Skov Wehner7, Henrik Hasle8, Lis Ørgaard Adamsen9,10, Kjeld Schmiegelow1,2, Hanne Bækgaard Larsen11.
Abstract
BACKGROUND: Children with cancer experience impaired cardiorespiratory fitness and physical function during and after treatment restricting their possibilities to engage in social activities including sport, leisure activities, and school. The objectives were to determine the effects of classmate-supported, controlled, supervised, in-hospital, physical activity program to preserve cardiorespiratory fitness and physical function from time of diagnosis in children with cancer.Entities:
Keywords: Cardiorespiratory fitness; Childhood cancer; Exercise
Mesh:
Year: 2020 PMID: 32624004 PMCID: PMC7336676 DOI: 10.1186/s12916-020-01634-6
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Fig. 1CONSORT diagram of the enrollment process in the RESPECT study. RESPECT, Rehabilitation including Social and Physical Activity and Education in Children and Teenagers with Cancer
The in-hospital RESPECT activity program
| Training/weekday | Monday | Tuesday | Wednesday | Thursday | Friday | Weekends |
|---|---|---|---|---|---|---|
| Able to walk/not isolated | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | Group session 30–120 min Cardiorespiratory fitness Muscle strength Balance | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | Group session 30–120 min Cardiorespiratory fitness Muscle strength Balance | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | No training |
| Able to walk/isolated | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | Individual session 5–30 min Cardiorespiratory fitness Muscle strength Balance | No training |
| Bedridden | Individual session 5–30 min Muscle strength | Individual session 5–30 min Muscle strength | Individual session 5–30 min Muscle strength | Individual session 5–30 min Muscle strength | Individual session 5–30 min Muscle strength | No training |
RESPECT Rehabilitation including Social and Physical Activity and Education in Children and Teenagers with Cancer
Fig. 2Flow chart of the study timeline
Anthropometric and clinical characteristics
| Anthropometric characteristics | Intervention ( | Control ( | Ambassadors ( | Healthy age- and sex-matched children ( | |
|---|---|---|---|---|---|
| Sex (males/females) | 75/45 (62.5%/37.5%) | 31/23 (57%/43%) | 0.61 | 37/25 (60%/40%) | 180/75 (71%/29%) |
| Age (years) | 11.2 ± 3.1 | 11.0 ± 3.2 | 0.44 | 11.9 ± 2.5 | 12.9 ± 3.1 |
| Height (m) | 1.52 ± 0.19 | 1.50 ± 0.2 | 0.69 | 1.57 ± 0.16 | 1.58 ± 0.19 |
| Weight (kg) | 44.8 ± 17.2 | 41.0 ± 14.0 | 0.21 | 48.4 ± 16.2 | 49.4 ± 16.9 |
| BMI (kg/m2) | 18.5 ± 4.0 | 17.6 ± 2.5 | 0.10 | 19.0 ± 3.6 | 17.9 ± 5.2 |
| Leukemia | 47 (39%) | 23 (46%) | |||
| Lymphoma | 22 (18%) | 8 (16%) | |||
| Extracranial solid tumors | 35 (29%) | 14 (28%) | |||
| Central nervous system tumor | 11 (9%) | 5 (10%) | |||
| Other hematological disease | 5 (4%) | 0 (0%) | 0.61 | ||
| NOPHO ALL 2008 | 34 | 20 | |||
| NOPHO-DBH-AML 2012 | 11 | 3 | |||
| ICC APL 01 | 2 | 0 | |||
| Euro-LB-02 | 4 | 0 | |||
| Euro NET PHL-C1 interrim | 6 | 0 | |||
| Euro NET PHL-C2 | 2 | 4 | |||
| BFM NHL 2004 | 7 | 0 | |||
| BFM NHL 2013 | 3 | 4 | |||
| Euro-Ewing 99 | 11 | 2 | |||
| EURAMOS-1 | 6 | 4 | |||
| CCLG interim | 1 | 0 | |||
| EpSSG RMS 2005 | 7 | 4 | |||
| EpSSG-NRSTS 2005 | 5 | 0 | |||
| UKSSG | 0 | 1 | |||
| SIOPEL 6- SR | 1 | 0 | |||
| SIOPEL. high risk-PLADO | 1 | 0 | |||
| Neoadjuvant (docetaxel/cisplatin/fluorouracil) | 1 | 0 | |||
| SIOP-CNS GCT 2 | 3 | 2 | |||
| SIOP ependynoma 2 | 2 | 0 | |||
| (EU-RHAB) 2009 | 1 | 1 | |||
| Angiocomb | 0 | 1 | |||
| Herby study | 0 | 2 | |||
| SIOP PNET 5 | 3 | 1 | |||
| SIOP- LGG 2004 | 1 | 1 | |||
| LCH-III | 1 | 0 | |||
| Allogeneic transplantation | 4 | 0 | |||
| Other | 1 | 0 | |||
| No chemotherapy | 2 | 0 | |||
| Chemotherapy | 118 | 50 | |||
| Radiation therapy | 25 | 10 | |||
| Surgery | 40 | 18 | |||
| Central nervous system | 11 | 5 | |||
| Head | 6 | 3 | |||
| Torso | 13 | 6 | |||
| Upper extremity | 3 | 0 | |||
| Lower extremity | 13 | 5 | |||
Descriptive data are presented as mean and standard deviations or frequency and percentage
Effects of the RESPECT activity program on cardiorespiratory fitness and physical function
| Baseline | 3 months | 6 months | Group ( | Time ( | Change over time between groups per week (mean, 95% CI) | Change over time between groups ( | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| INT | 38 | 27.4 ± 6.97 | 30 | 26.1 ± 6.1 | 34 | 29.6 ± 6.9 | 0.2830 | 0.1415 | 0.25 [0.07 to 0.43] | 0.0062 |
| CON | 13 | 27.8 ± 8.3 | 13 | 23.8 ± 5.9 | 10 | 22.1 ± 5.8 | 0.0238 | |||
| INT | 38 | 107.6 ± 33.1 | 30 | 95.5 ± 34.9 | 30 | 112.6 ± 49.5 | 0.0438 | 0.0185 | 0.21 [0.07 to 0.35] | 0.0038 |
| CON | 13 | 113.1 ± 63.8 | 13 | 90 ± 45.1 | 10 | 69 ± 27 | 0.0694 | |||
| INT | 90 | 25.1 ± 6.4 | 74 | 24.2 ± 7.2 | 81 | 24.6 ± 8.1 | < 0.0001 | 0.4960 | 0.04 [− 0.08 to 017] | 0.5057 |
| CON | 26 | 18.0 ± 5.0 | 38 | 16.5 ± 6.8 | 28 | 17.6 ± 7.3 | 0.8919 | |||
| INT | 85 | 4.0 ± 0.8 | 74 | 4.3 ± 1.1 | 82 | 4.1 ± 1.2 | < 0.0001 | 0.3038 | 0.02 [− 0.09 to 0.04]* | 0.4129 |
| CON | 27 | 5.5 ± 1.7 | 38 | 6.0 ± 1.9 | 27 | 6.4 ± 3.3 | ||||
| INT | 103 | 21.4 ± 11.4 | 90 | 19.3 ± 10.5 | 91 | 20.1 ± 11.4 | 0.3418 | 0.4085 | − 0.01 [− 029 to 0.27] | 0.9438 |
| CON | 28 | 17.1 ± 9.7 | 39 | 12.1 ± 8.2 | 30 | 12.7 ± 8.5 | 0.0711 | |||
| INT | 104 | 20.0 ± 10.8 | 90 | 17.4 ± 10.2 | 90 | 18.5 ± 10.7 | 0.0032 | 0.0062 | 0.01 [−0.002 to 0.02] | 0.1668 |
| CON | 28 | 16.6 ± 10.4 | 39 | 10.5 ± 7.6 | 30 | 12.0 ± 8.4 | 0.0466 | |||
| INT | 98 | 0 [0 to 7] | 86 | 0 [0 to 18] | 87 | 0 [0 to 16] | < 0.0001 | < 0.0001 | 0.5846 | |
| CON | 27 | 0 [0 to 13] | 37 | 1 [0 to 26] | 27 | 1 [0 to 26] | < 0.0001 | |||
VO2peak, sit-to-stand, timed-up-and-go, and handgrip strength are reported in mean and standard deviation, and flamingo balance is reported in median and range. All analysis is adjusted for age, sex, and diagnosis (hematological versus oncological)
INT the intervention group, CON the control group
*The interaction effect in TUG is presented in percentages
Comparisons of cardiorespiratory fitness and physical function between children with cancer and healthy age-and sex-matched children at baseline (median of 12 days in the intervention group and 27 days in the control group)
| Intervention group | Control group | Subgroup of ambassadors | Historic healthy age- and sex-matched children | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 38 | 27.4 ± 6.97 | < 0.0001 | 13 | 27.8 ± 8.30 | < 0.0001 | 255 | 47.7 ± 7.7 | |||
| 90 | 25.1 ± 6.4 | < 0.0001 | 26 | 18.0 ± 5.0 | < 0.0001 | 62 | 31.8 ± 4.5 | |||
| 85 | 4.0 ± 0.8 | < 0.0001 | 27 | 5.5 ± 1.7 | < 0.0001 | 61 | 3.3 ± 0.4 | |||
| 103 | 21.4 ± 11.4 | 0.002 | 28 | 17.1 ± 9.7 | < 0.0001 | 63 | 26.8 ± 12.8 | |||
| 104 | 20.0 ± 10.8 | < 0.0001 | 28 | 16.6 ± 10.4 | < 0.0001 | 63 | 24.3 ± 11.8 |
VO2peak, sit-to-stand, timed-up-and-go, and handgrip strength are reported in mean and standard deviation. The p values represent a comparison between a patient group (the intervention group and the control group) and a group of healthy children (the subgroup of ambassadors or historic healthy age- and sex-matched children)